Physician profile
Daniel Einhorn
NPI 1215996186
$12,848.36
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $825 · 2020: $7,194 · 2021: $3,645 · 2022: $1,184.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,887.80 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $270.50 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $268.90 | 2019-2022 | |
| Bardy Diagnostics, INC. | $245.00 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $223.73 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $204.10 | 2019-2022 | |
| Boston Scientific Corporation | $203.68 | 2019-2022 | |
| Novo Nordisk INC | $189.70 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $146.95 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $143.08 | 2020-2022 | |
| Amgen INC. | $118.98 | 2019-2022 | |
| Pfizer INC. | $115.51 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $102.80 | 2019 | |
| Esperion Therapeutics, INC. | $87.32 | 2021 | |
| Amarin Pharma, INC. | $83.91 | 2020-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $72.61 | 2019-2020 | |
| Edwards Lifesciences Corporation | $68.11 | 2019-2022 | |
| Astellas Pharma US INC | $61.09 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $45.65 | 2021-2022 | |
| Tactile Systems Technology INC | $38.18 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $38.15 | 2020-2021 | |
| Impulse Dynamics (USA) INC. | $32.18 | 2022 | |
| Alnylam Pharmaceuticals INC. | $31.19 | 2021-2022 | |
| Philips North America LLC | $30.15 | 2022 | |
| Medtronic, INC. | $29.57 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $25.61 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $25.49 | 2021 | |
| Biocompatibles, INC. | $24.51 | 2019 | |
| Atricure, INC. | $20.30 | 2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $13.61 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Einhorn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.